Compare Stocks

Date Range: 

 OraSure TechnologiesCerusBioventusNyxoahOrthofix Medical
SymbolNASDAQ:OSURNASDAQ:CERSNYSE:BVSNASDAQ:NYXHNASDAQ:OFIX
Price Information
Current Price$11.18$6.68$14.91$30.66$39.32
50-Day Moving Average$11.12$5.91$15.23$31.30$40.01
52-Week Low$8.58$4.67$10.74$23.15$28.32
52-Week High$17.79$8.87$19.94$37.00$48.50
MarketRank™
Overall Score2.31.62.31.71.7
Analysis Score3.30.03.43.51.0
Community Score4.84.95.05.04.1
Dividend Score0.00.00.00.00.0
Ownership Score1.72.51.70.01.7
Earnings & Valuation Score1.90.61.30.01.9
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyHold
Consensus Price Target$15.83N/A$19.50$42.00$39.00
% Upside from Price Target41.62% upsideN/A30.78% upside36.99% upside-0.81% downside
Trade Information
Market Cap$805.06 million$1.15 billion$847.62 million$764.75 million$774.41 million
Beta-0.281.22N/AN/A1.13
Average Volume972,6751,803,940194,84521,33288,365
Sales & Book Value
Annual Revenue$171.72 million$91.92 million$321.16 millionN/A$406.56 million
Price / Sales4.6912.472.64N/A1.90
CashflowN/AN/AN/AN/A$1.96 per share
Price / CashN/AN/AN/AN/A20.04
Book Value$5.56 per share$0.62 per shareN/AN/A$18.37 per share
Price / Book2.0110.77N/A2.14
Profitability
Net Income$-14,920,000.00$-59,860,000.00$16.41 millionN/A$2.52 million
EPS($0.22)($0.37)$7.56N/A$0.26
Trailing P/E Ratio159.71N/A1.970.00N/A
Forward P/E Ratio53.24N/A18.41N/A31.71
P/E GrowthN/AN/AN/AN/AN/A
Net Margins2.34%-57.50%N/AN/A-1.78%
Return on Equity (ROE)1.33%-62.92%N/AN/A6.82%
Return on Assets (ROA)1.17%-27.93%N/AN/A4.73%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.65%0.76%N/A0.06%
Current Ratio6.12%2.82%1.83%N/A3.17%
Quick Ratio5.09%2.34%1.62%N/A2.17%
Ownership Information
Institutional Ownership Percentage88.63%88.16%36.45%0.77%95.68%
Insider Ownership Percentage1.70%6.72%N/AN/A4.00%
Miscellaneous
Employees570266700781,036
Shares Outstanding72.01 million171.63 million56.85 million24.94 million19.70 million
Next Earnings Date11/3/2021 (Estimated)11/4/2021 (Estimated)11/9/2021 (Estimated)11/30/2021 (Estimated)11/4/2021 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable
SourceHeadline
Orthofix Announces Appointment of Wayne Burris to Board of DirectorsOrthofix Announces Appointment of Wayne Burris to Board of Directors
finance.yahoo.com - September 23 at 9:34 AM
Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic ProceduresOrthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures
finance.yahoo.com - September 22 at 12:42 AM
Devicemaker launches bone void filler for orthopedic surgeriesDevicemaker launches bone void filler for orthopedic surgeries
beckersspine.com - September 21 at 7:41 PM
Press Release: Orthofix Announces Participation in Upcoming Sidoti Virtual Investor ConferencePress Release: Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference
sharecast.com - September 20 at 7:25 AM
Orthofix Announces Participation in Upcoming Sidoti Virtual Investor ConferenceOrthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference
finance.yahoo.com - September 20 at 7:25 AM
Medical Bionic Implants Market is Expected to Grow Drastically, Assured By Experts From 2021 To 2027Medical Bionic Implants Market is Expected to Grow Drastically, Assured By Experts From 2021 To 2027
globalbankingandfinance.com - September 18 at 5:45 PM
$118.25 Million in Sales Expected for Orthofix Medical Inc. (NASDAQ:OFIX) This Quarter$118.25 Million in Sales Expected for Orthofix Medical Inc. (NASDAQ:OFIX) This Quarter
americanbankingnews.com - September 16 at 2:28 AM
$0.17 Earnings Per Share Expected for Orthofix Medical Inc. (NASDAQ:OFIX) This Quarter$0.17 Earnings Per Share Expected for Orthofix Medical Inc. (NASDAQ:OFIX) This Quarter
americanbankingnews.com - September 14 at 5:16 PM
Bone Growth Stimulation Devices Market 2021 | Growth Drivers Challenges, Trends and Industry Dynamics, Forecast 2028Bone Growth Stimulation Devices Market 2021 | Growth Drivers Challenges, Trends and Industry Dynamics, Forecast 2028
pharmiweb.com - September 10 at 2:30 AM
Orthofix Medicals Return on Invested Capital InsightsOrthofix Medical's Return on Invested Capital Insights
benzinga.com - September 9 at 4:10 PM
Orthofix Medical (NASDAQ:OFIX) Releases FY 2021 Earnings GuidanceOrthofix Medical (NASDAQ:OFIX) Releases FY 2021 Earnings Guidance
americanbankingnews.com - September 3 at 7:24 AM
Orthofix (OFIX) Fitbone Used in 1st US Pediatric Patient ImplantOrthofix (OFIX) Fitbone Used in 1st US Pediatric Patient Implant
finance.yahoo.com - September 2 at 5:21 PM
Zimmer Biomets smart knee implant, Aurora Spines Q2 results & more: 7 device company notesZimmer Biomet's smart knee implant, Aurora Spine's Q2 results & more: 7 device company notes
beckersspine.com - September 1 at 5:17 PM
Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening SystemOrthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System
finance.yahoo.com - September 1 at 7:11 AM
Orthofix Medical Inc. (NASDAQ:OFIX) Short Interest Up 22.6% in AugustOrthofix Medical Inc. (NASDAQ:OFIX) Short Interest Up 22.6% in August
americanbankingnews.com - August 31 at 3:50 PM
Spinal Devices and Biologics Market Leading Players: Recent Industry Trends, Global Insights and Demand Growth, Size, Revenue 2021 to 2027Spinal Devices and Biologics Market Leading Players: Recent Industry Trends, Global Insights and Demand Growth, Size, Revenue 2021 to 2027
marketwatch.com - August 26 at 3:28 PM
Orthofix Medical Inc.’S 3.81% Escalation Justifies Another LookOrthofix Medical Inc.’S 3.81% Escalation Justifies Another Look
stocksregister.com - August 21 at 4:35 PM
Orthofix Medical Inc.Orthofix Medical Inc.
barrons.com - August 12 at 10:36 PM
Spine Surgery Medical Equipment Market 2021 Covid19 Impact Analysis Players are Medtronic (Ireland), DePuy Synthes (US)Spine Surgery Medical Equipment Market 2021 Covid19 Impact Analysis Players are Medtronic (Ireland), DePuy Synthes (US)
manometcurrent.com - August 9 at 2:20 PM
How Much Did Orthofix Medicals(NASDAQ:OFIX) Shareholders Earn From Share Price Movements Over The Last Three Years?How Much Did Orthofix Medical's(NASDAQ:OFIX) Shareholders Earn From Share Price Movements Over The Last Three Years?
finance.yahoo.com - August 9 at 2:20 PM
Orthofix Stock Ticks Up On Street-Beating Q2 Earnings; Raises FY21 OutlookOrthofix Stock Ticks Up On Street-Beating Q2 Earnings; Raises FY21 Outlook
markets.businessinsider.com - August 6 at 7:04 PM
Orthofix ticks up on Street-beating Q2 resultsOrthofix ticks up on Street-beating Q2 results
massdevice.com - August 6 at 2:04 PM
Orthofix (OFIX) Tops Q2 Earnings and Revenue EstimatesOrthofix (OFIX) Tops Q2 Earnings and Revenue Estimates
finance.yahoo.com - August 6 at 2:04 PM
Orthofix: Q2 Earnings SnapshotOrthofix: Q2 Earnings Snapshot
sfgate.com - August 6 at 9:04 AM
Orthofix Medical: Q2 Earnings InsightsOrthofix Medical: Q2 Earnings Insights
benzinga.com - August 6 at 9:04 AM
DateCompanyBrokerageAction
9/22/2021OraSure TechnologiesRaymond James
Downgrade
9/20/2021OraSure TechnologiesLake Street Capital
Boost Price Target
8/4/2021OraSure TechnologiesRaymond James
Boost Price Target
8/4/2021OraSure TechnologiesLake Street Capital
Lower Price Target
8/4/2021OraSure TechnologiesCitigroup
Boost Price Target
7/28/2021NyxoahCantor Fitzgerald
Initiated Coverage
7/28/2021NyxoahPiper Sandler
Initiated Coverage
7/27/2021NyxoahStifel Nicolaus
Initiated Coverage
7/6/2021NyxoahKepler Capital Markets
Reiterated Rating
7/1/2021BioventusThe Goldman Sachs Group
Downgrade
6/28/2021OraSure TechnologiesRaymond James
Lower Price Target
5/25/2021BioventusCanaccord Genuity
Reiterated Rating
5/6/2021OraSure TechnologiesLake Street Capital
Lower Price Target
5/6/2021OraSure TechnologiesRaymond James
Lower Price Target
4/19/2021BioventusMorgan Stanley
Boost Price Target
3/8/2021BioventusJPMorgan Chase & Co.
Initiated Coverage
3/8/2021BioventusMorgan Stanley
Initiated Coverage
3/8/2021BioventusThe Goldman Sachs Group
Initiated Coverage
3/8/2021BioventusCanaccord Genuity
Initiated Coverage
3/2/2021OraSure TechnologiesCitigroup
Lower Price Target
10/20/2020Orthofix MedicalStifel Nicolaus
Initiated Coverage
8/21/2020OraSure TechnologiesEvercore ISI
Initiated Coverage
8/10/2020OraSure TechnologiesCitigroup
Initiated Coverage
8/10/2020OraSure TechnologiesJPMorgan Chase & Co.
Initiated Coverage
8/7/2020OraSure TechnologiesRaymond James
Upgrade
6/25/2020OraSure TechnologiesLake Street Capital
Initiated Coverage
6/15/2020CerusCantor Fitzgerald
Initiated Coverage
6/8/2020CerusCantor Fitzgerald
Reiterated Rating
5/27/2020CerusStifel Nicolaus
Boost Price Target
4/21/2020OraSure TechnologiesStephens
Initiated Coverage
4/16/2020CerusStephens
Lower Price Target
2/26/2020CerusBTIG Research
Initiated Coverage
2/25/2020Orthofix MedicalSidoti
Lower Price Target
2/25/2020Orthofix MedicalCantor Fitzgerald
Lower Price Target
11/13/2019CerusBTIG Research
Upgrade
11/11/2019OraSure TechnologiesCanaccord Genuity
Reiterated Rating
10/29/2019Orthofix MedicalCantor Fitzgerald
Downgrade
8/27/2019CerusStifel Nicolaus
Initiated Coverage
8/22/2019CerusStephens
Initiated Coverage
8/14/2019OraSure TechnologiesCanaccord Genuity
Reiterated Rating
5/9/2019OraSure TechnologiesCanaccord Genuity
Downgrade
2/26/2019Orthofix MedicalBTIG Research
Reiterated Rating
2/7/2019OraSure TechnologiesCanaccord Genuity
Reiterated Rating
1/18/2019Orthofix MedicalCantor Fitzgerald
Set Price Target
1/8/2019Orthofix MedicalCantor Fitzgerald
Set Price Target
12/18/2018CerusCantor Fitzgerald
Reiterated Rating
12/10/2018CerusCantor Fitzgerald
Reiterated Rating
10/23/2018OraSure TechnologiesRaymond James
Reiterated Rating
10/3/2018CerusCantor Fitzgerald
Reiterated Rating
(Data available from 9/23/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.